Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Anavex Life Sciences Corporation AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer . Its lead drug candidate, ANAVEX 2-73 (blarcamesine),... see more

Current News (NDAQ:AVXL)

Anavex Life Sciences to Present at the Citizens Life Sciences Conference

GlobeNewswire 13 days ago

Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference

GlobeNewswire February 25, 2026

Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors

GlobeNewswire February 23, 2026

Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update

GlobeNewswire February 9, 2026

Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026

GlobeNewswire February 3, 2026

Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer's Disease

GlobeNewswire January 13, 2026

Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology

GlobeNewswire January 8, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

ACCESS Newswire January 7, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anavex Life Sciences Corp. - AVXL

GlobeNewswire January 6, 2026
View More News ››

Opinion & Analysis (NDAQ:AVXL)

Analyst Believes Biopharma's Alzheimer's Treatment Could Be Superior to Biogen's

Streetwise Reports December 11, 2019

EMA Opinion Bodes Well for Biopharma's Drug Getting Orphan Status

Streetwise Reports August 1, 2019
View More Opinion ››

Bullboard Posts (NDAQ:AVXL)

Sell buddy sell.Wow.

Otherwise you guys out there will be losing your shorts with this stock today
coolfooldumbguy - November 14, 2025

Who knows what we don't ?

collapse
Galaxym31 - November 13, 2025

Seems to me this drug for Alzheimer's disease should be

used to treat people worldwide ASAP. Whats the holdup ?
Galaxym31 - October 30, 2025

How can this treatment not be worth billions ?

$$$$$$
Galaxym31 - October 1, 2025

Should be much higher IMO

.
Galaxym31 - September 30, 2025

Not a lot of respect here….

For their data.  Seems like everyone is doubting efficacy.  But the approved products are NG also?  Well if the pharma...
hoffbag - November 25, 2023
View more Bullboard ››

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc. engages in the acquisition, exploration, and development of mineral properties in North ...
View More »

Podcasts